Clinical Chemistry Arndt T., van der Meijden B.B., Wielders J.P.M., (2008) Atypical serum transferrin isoform distribution in liver cirrhosis studied by HPLC, capillary electrophoresis and transferrin genotyping. Clinica Chimica Acta, 394(1-2), 42-46. PubMed Helander, A., Husa, A., & Jeppsson, J.O., (2003) Improved HPLC method for carbohydrate-deficient transferrin in serum. Clinical Chemistry, 49(11), 1881-1890. PubMed Jeppsson, J.O., Arndt, T., Schellenberg, F., Wielders, J.P., Anton, R.F., Whitfield, J.B., & Helander, A., (IFCC-WG-CDT), (2007) Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clinical Chemistry and Laboratory Medicine, 45(4), 558-562. PubMed Kapoor, A., Kraemer, KL., Smith, KJ., roberts, MS., Saitz, R. (2009) Cost-effectiveness of screening for unhealthy alcohol use with % carbohydrate deficient transferrin: results from a literature-based decision analytic computer model. Alcoholism Clinical and Experimental Research, 33(8), 1440-9. PubMed Addiction Specialists Anton R. F., Lieber C., Tabakoff B., & CDTect Study Group, (2002). Carbohydrate-deficient transferrin and gamma-Glutamyltransferase for the detection and monitoring of alcohol use: Results from a multisite study. Alcoholism: Clinical and Experimental Research, 26(8), 1215-1222. PubMed Center for Substance Abuse Treatment, (2006). The role of biomarkers in the treatment of alcohol use disorders. Substance Abuse Treatment Advisory, 5(4), 1-8. Cluver, J. S., Miller, P.M., & Anton, R. F., (2007). Case studies of the utility of serum carbohydrate-deficient transferrin (%CDT) in the clinical management of alcoholics. Journal of Addiction Medicine, 1(1), 44-47. Fleming, M. F., Anton, R. F., & Spies, C. D., (2004). A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcoholism: Clinical and Experimental Research, 28(9), 1347-1355. PubMed Miller, P. M., Dominick, C. S., & Anton, R. F., (2004). Carbohydrate-deficient transferrin test: A tool for detecting alcohol abuse. Current Psychiatry, 5(6), 80-87. Kapoor, A., Draemer, K.L., Smith, K.J., Robers, M.S., & Saitz, R., (2009). Cost-Effectiveness of Screening for Inhealthy Alcohol Use with %Carbohydrate Deficient Transferrin: REsults From a Literature-Based Decision analytic Comptuer Model. Alcoholism: Clinical and Experimental Research, 33(6), 1-10. PubMed Surgery and Internal Medicine Dillie, K. S., Mundt, M., French, M. T., & Fleming, M. F., (2005). Cost-benefit analysis of a new alcohol biomarker, carbohydrate-deficient transferrin, in a chronic illness primary care sample. Alcoholism: Clinical And Experimental Research, 29(11), 2008-2014. PubMed Miller, P. M., & Anton, R. F., (2004). Biochemical alcohol screening in primary healthcare. Addictive Behaviors, 29(7), 1427-1437. PubMed Miller, P. M., Spies, C., Neumann, T., Javos, M. A., Hoyumpa, A. M., Roache, J., Webb, A., Kashi, M., Sharkey, F. E., Anton, R. F., Egan, B. M., Basile, J., Nguyen, S., Fleming, M. F., Dillie, K. S., (2006). Alcohol biomarker screening in medical and surgical settings. Alcoholism: Clinical and Experimental Research, 30(2), 185-193. PubMed Spies, C. D., Kissner, M., Neumann, T., Blum, S., Voigt, C., Funk, T., Runkel, N., & Pragst, F., (1998). Elevated carbohydrate-deficient transferrin predicts prolonged intensive care unit stay in traumatized men. Alcohol & Alcoholism, 33(6), 661-669. PubMed Clinical Neurobiology Laboratory
67 President St. PH144
Charleston, SC 29425
Ph. (843) 792-5441 Fax (843) 792-7371
E-mail: cnl@musc.edu |
